English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

CFDA Proposes Changes to Foreign Drug Registration

Mar. 17, 2017

The CFDA has published suggested amendments to its foreign drug registration rules. The proposed amendments are designed to overcome the present hurdles associated with foreign-approved drug registration in China.

The proposal suggests opening up China to multi-center global trials and admitting the results obtained from such trials in the local drug registration process.

If implemented, the proposal may save years of local parallel development and shorten the time-to-market of new drugs, to the benefit of both pharma companies and the general public.